Anatomical Variation in Mesenteric Macrophage Phenotypes in Crohn's Disease

Jonathan H M van der Meer1, Karin A T G M Wasmann2, Jarmila D W van der Bilt2,3

  • 1Department of Gastroenterology and Hepatology, Amsterdam Gastroenterology & Metabolism, Tytgat Institute for Liver and Intestinal Research, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.

Abstract

Insights

Extended ileocecal resection is not supported for Crohn's disease. Macrophage analysis reveals distinct immunological profiles in the mesorectum versus ileocecal mesentery, lacking evidence for enhanced resection benefits.

Area of Science:

  • Gastroenterology
  • Immunology
  • Surgical Oncology

Background:

  • Crohn's disease recurrence after ileocecal resection is a significant clinical challenge.
  • Resection of the mesorectum during proctectomy is linked to reduced inflammation and better healing.
  • The immunological role of the ileocecal mesentery in Crohn's disease is not well understood.

Purpose of the Study:

  • To characterize macrophages in the ileocecal mesentery and compare them to the mesorectum.
  • To provide a biological rationale for ongoing clinical trials investigating extended mesenteric resection in Crohn's disease.

Main Methods:

  • Tissue specimens were collected from the mesorectum and ileocecal mesentery of patients with Crohn's disease and controls.
  • Immune cells were analyzed using flow cytometry for CD206 expression to assess macrophage inflammatory status.

Main Results:

  • The mesorectum exhibited a gradient of macrophages from proinflammatory to regulatory.
  • The ileocecal mesentery showed fewer proinflammatory macrophages near inflamed tissue, with a trend towards a proinflammatory phenotype centrally.

Conclusions:

  • The mesorectum and ileocecal mesentery possess distinct immunological characteristics.
  • Current data do not support extended ileocecal resection for Crohn's disease based on macrophage profiles.